Skip to main content
. 2022 Apr 29;9:876795. doi: 10.3389/fcvm.2022.876795

Table 2.

Bivariate and multivariate meta-regression models with the hazard ratio for major adverse cardiovascular events (MACE) as dependent variable.

HR 95% CI p
Lower bound Upper bound
Bivariate analyses
Achieved HbA1c at study end in the active arm (HbA1c ≤ 7.0% vs HbA1c > 7.0%) vs MACE
All trials
(143 study arms; n = 270,874; 20,724 events)
0.9579 0.8117 1.1097 0.256
SGLT2i, DPP4i, Pioglitazone or GLP1-RA in the active arm
(73 study arms*; n = 197,498; 17,073 events)
0.9062 0.7985 0.9673 0.017
Change in HbA1c in the active arm compared to control (each reduction of 1%) vs MACE
All trials
(143 study arms; n=270,874; 20,724 events)
0.8979 0.7249 1.0171 0.109
SGLT2i, DPP4i, Pioglitazone or GLP1-RA in the active arm
(73 study arms*; n = 197,498; 17,073 events)
0.8477 0.7395 0.9246 <0.001
Multivariate analyses**
Achieved HbA1c at study end in the active arm (HbA1c ≤ 7.0% vs. HbA1c > 7.0%) vs. MACE
All trials‡‡
(121 study arms§; n = 243,713; 18,029 events)
0.8785 0.6471 1.0820 0.162
SGLT2i, DPP4i, Pioglitazone or GLP1-RA in the active arm
(60 study arms*§; n = 191,032; 16,126 events)
0.8252 0.7111 0.9512 0.009
Change in HbA1c in the active arm compared to control (each reduction of 1%) vs. MACE
All trialsøø
(119 study arms§; n = 240,227; 17,648 events)
0.8837 0.7019 0.9991 0.049
SGLT2i, DPP4i, Pioglitazone or GLP1-RA in the active arm◇◇
(60 study arms*§; n = 191,032; 16,126 events)
0.9046 0.7513 0.9798 0.011
*

Excluding RCTs with outlier HRs for MACE, defined as HR ≥ 2.0 or HR ≤ 0.5.

**

Adjusted for Time since the diagnosis of T2DM, follow-up time and type of ADT in the active arm. Adjusting variables were selected for their association with HR for MACE in bivariate analyses.

§

Some RCTs had missing data for covariates.

I2: 5.31%, QE = 83.17 (p = 0.95); tau2: 0.010 (SE = 0.022).

I2: 12.12%, QE = 53.32 (p = 0.93); tau2: 0.010 (SE = 0.022).

ø

I2: 2.76%, QE = 92.10 (p = 0.98); tau2: 0.010 (SE = 0.022).

I2: 6.1%, QE = 67.55 (p = 0.98); tau2: 0.008 (SE = 0.023).

‡‡

I2: 0%, QE = 73.21 (p = 0.95); tau2: 0.014 (SE = 0.012).

I2: 0%, QE = 7.29 (p = 0.20); tau2: 0.010 (SE = 0.021).

øø

I2: 0%, QE = 85.56 (p = 0.98); tau2: 0.018 (SE = 0.027).

◇◇

I2: 0%, QE = 77.32 (p = 0.96); tau2: 0.008 (SE = 0.028).